Expression of Serum Exosomal MicroRNA-21 in Human Hepatocellular Carcinoma

Hongwei Wang, Lijuan Hou, Aihui Li, Yuxiu Duan, Haili Gao, Xinwen Song

BioMed Research International · 2014 · 289 citations · 19 references

DOIFull text

Open access

Concepts

TL;DR

HCC diagnosis urgently needs new strategies, and microRNAs are increasingly viewed as disease biomarkers. The study examined serum exosomal miR‑21 expression in HCC versus chronic hepatitis B patients to assess its clinical relevance. They measured miR‑21 levels by quantitative RT‑PCR in serum exosomes, exosome‑depleted supernatants, and whole serum. Serum exosomal miR‑21 was markedly enriched compared to whole serum, was significantly higher in HCC patients than in CHB or healthy controls, correlated with cirrhosis and advanced tumor stage, and thus offers greater diagnostic sensitivity and may serve as a potential HCC biomarker.

Abstract

New strategies for the diagnosis of hepatocellular carcinoma (HCC) are urgently needed. There is an increasing interest in using microRNAs (miRNAs) as biomarkers in diseases. In this study, we examined the expression of miR-21 in serum exosomes from patients with HCC or chronic hepatitis B (CHB) and investigated the potential clinical significance of miR-21. Quantitative RT-PCR indicated that the concentration of miR-21 was significantly higher in exosomes than in exosome-depleted supernatants or the whole serum. Further, the expression level of serum exosomal miR-21 was significantly higher in patients with HCC than those with CHB or healthy volunteers (P < 0.0001, P < 0.0001, resp.). High level of miR-21 expression correlated with cirrhosis (P = 0.024) and advanced tumor stage (P = 0.001). Although serum level of miR-21 was higher in patients with HCC than in patients with CHB and healthy volunteers, the sensitivity of detection is much lower than using exosomal miR-21. These findings indicate that miR-21 is enriched in serum exosomes which provides increased sensitivity of detection than whole serum. Exosomal miR-21 may serve as a potential biomarker for HCC diagnosis.

References

19